euro adhoc: Curanum AG / Financial Figures/Balance Sheet / CURANUM AG: Audit of 2005 annual financial statements concluded, figures confirmed

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc.
The issuer is responsible for the content of this announcement.
--------------------------------------------------------------------------------

28.04.2006

The audit of the 2005 annual financial statements of CURANUM AG,
Munich, was today concluded with the issue of the audit certificate.
The key figures already announced for sales (EUR 188.5 million),
EBITDA (EUR 25.8 million), EBIT (EUR 19.6 million) and EBT (EUR 12.2
million) remained unchanged. While earnings after taxes, at EUR 7.3
million (PY: EUR 4.9 million) were EUR 0.2 million lower than the
published figure, cash flow, at EUR 12.7 million, exceeded the
previously announced figure by EUR 0.4 million (PY: EUR 21.4
million). EPS were thus EUR 0.25 (PY: EUR 0.17), an increase of 47%
compared to the previous year. As already announced, the auditors
issued the financial statements with a qualified audit opinion.

The Management Board is assuming that, in the current situation, the
Company’s shareholders will benefit more from rapid and profitable
growth than from the payment of a higher dividend. Since the care
market is currently offering many favourable opportunities for
acquisitions, the Management and Supervisory Boards will propose to
the Annual General Meeting the distribution of EUR 0.10 per share, in
total EUR 3.0 million, from distributable reserves of EUR 12.6
million (PY: EUR 10.4 million)

Munich, 28 April 2006

The Management Board

--------------------------End of Ad hoc
report--------------------------------

Explanation of qualification of audit certificate:

The auditors issued a qualified audit certificate on several grounds,
which the Management Board of CURANUM AG either deem to be incorrect
or on which the Management Board hold a different opinion. The
Company will supply a table providing a detailed explanation of the
different standpoints and their consequences upon request. CEO
Hans-Milo Halhuber will also explain the relevant matters as a part
of a conference call and following Q&A session on Tuesday 2 May 2006,
at 10.00 hrs.

end of announcement euro adhoc 28.04.2006 17:35:51
--------------------------------------------------------------------------------

ots Originaltext: Curanum AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Bernd Rothe
Tel.: +49 (0)89 242065-60
E-Mail: bernd.rothe@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: CDAX, Classic All Share, Prime All Share, SDAX
Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime
standard
Bayerische Börse / regulated dealing
Börse Berlin-Bremen / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade